Mikael von Euler

941 total citations
12 papers, 531 citations indexed

About

Mikael von Euler is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Mikael von Euler has authored 12 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Biotechnology. Recurrent topics in Mikael von Euler's work include Cancer Research and Treatments (4 papers), Testicular diseases and treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). Mikael von Euler is often cited by papers focused on Cancer Research and Treatments (4 papers), Testicular diseases and treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). Mikael von Euler collaborates with scholars based in Sweden, United Kingdom and Finland. Mikael von Euler's co-authors include Aman U. Buzdar, Mark L. Steinberg, Alan Webster, Tarek Sahmoud, John F. R. Robertson, J. Bonneterre, Olof Söder, Pasi Pöllänen, Per Andersson and Bristi Basu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Mikael von Euler

11 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikael von Euler Sweden	6	337	257	255	137	108	12	531
Patricia Farmer Canada	7	398 1.2×	271 1.1×	381 1.5×	102 0.7×	148 1.4×	10	744
N. Wilking Sweden	5	307 0.9×	145 0.6×	189 0.7×	57 0.4×	90 0.8×	11	543
M. Gershanovich Russia	9	446 1.3×	324 1.3×	322 1.3×	139 1.0×	70 0.6×	11	599
Matilde Pensabene Italy	16	161 0.5×	141 0.5×	234 0.9×	194 1.4×	184 1.7×	35	597
Ulrike Hornberger Switzerland	4	445 1.3×	292 1.1×	298 1.2×	144 1.1×	64 0.6×	4	580
O. Olopade United States	3	453 1.3×	315 1.2×	179 0.7×	88 0.6×	148 1.4×	4	693
Jožica Červek Slovenia	13	346 1.0×	275 1.1×	375 1.5×	202 1.5×	100 0.9×	18	707
M. Azab United Kingdom	6	390 1.2×	303 1.2×	547 2.1×	228 1.7×	156 1.4×	7	845
Roswitha Kammler Switzerland	9	263 0.8×	212 0.8×	444 1.7×	231 1.7×	118 1.1×	26	721
Juliette Murray United Kingdom	11	275 0.8×	276 1.1×	312 1.2×	90 0.7×	137 1.3×	27	532

Countries citing papers authored by Mikael von Euler

Since Specialization

Citations

This map shows the geographic impact of Mikael von Euler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael von Euler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael von Euler more than expected).

Fields of papers citing papers by Mikael von Euler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael von Euler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael von Euler. The network helps show where Mikael von Euler may publish in the future.

Co-authorship network of co-authors of Mikael von Euler

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael von Euler. A scholar is included among the top collaborators of Mikael von Euler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael von Euler. Mikael von Euler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dahlén, Torsten, et al.. (2024). Frequency of comedication of proton pump inhibitors with crystalline dasatinib in chronic myeloid leukemia and effects on TKI-bioavailability.. Journal of Clinical Oncology. 42(16_suppl). 6561–6561. 1 indexed citations

Gourley, Charlie, John Green, Hani Gabra, et al.. (2016). PISARRO: A EUTROC phase Ib study of APR-246 in combination with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in platinum sensitive relapsed high grade serous ovarian cancer (HGSOC).. Journal of Clinical Oncology. 34(15_suppl). 5571–5571. 16 indexed citations

Gourley, Charlie, Hani Gabra, Ignace Vergote, et al.. (2015). EUTROC PiSARRO: A phase Ib study combining APR-246 with standard chemotherapy in platinum sensitive relapsed high grade serous ovarian carcinoma (HGSOC).. Journal of Clinical Oncology. 33(15_suppl). TPS5605–TPS5605. 6 indexed citations

Pesonen, Sari, Johan Lundin, Nina Linder, et al.. (2015). Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). O16–O16. 1 indexed citations

Pesonen, Sari, Tuuli Ranki, Elke Jäger, et al.. (2015). An evaluation of local and systemic immune markers following intratumoral administration of a chimeric adenovirus Ad5/3-D24-GMCSF in refractory cancer patients with solid tumors.. Journal of Clinical Oncology. 33(15_suppl). 3085–3085.

Euler, Mikael von, Klas G. Wiman, Hani Gabra, et al.. (2015). Abstract CT204: Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer. Cancer Research. 75(15_Supplement). CT204–CT204. 1 indexed citations

Andersson, Per, Mikael von Euler, & Michael Beckert. (2014). Comparable pharmacokinetics of 85 mg RightSize nilotinib (XS003) and 150 mg Tasigna in healthy volunteers using a hybrid nanoparticle-based formulation platform for protein kinase inhibitors.. Journal of Clinical Oncology. 32(15_suppl). e13551–e13551. 8 indexed citations

Svechnikov, Konstantin, Mikael von Euler, Brian P. Setchell, et al.. (2005). Single Subcutaneous Administration of Chorionic Gonadotropin to Rats Induces a Rapid and Transient Increase in Testicular Expression of Pro-Inflammatory Cytokines. Pediatric Research. 57(6). 896–901. 15 indexed citations

Akaza, Hideyuki, Yasuo Ohashi, Tadashi Ikeda, et al.. (2002). [Post launch studies].. PubMed. 29(11). 2037–48. 2 indexed citations

10.

Bonneterre, J., Aman U. Buzdar, John F. R. Robertson, et al.. (2001). Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer. 92(9). 2247–2258. 437 indexed citations

11.

Jahnukainen, Kirsi, Teijo I. Saari, Toivo T. Salmi, et al.. (1995). Effects of testicular cytokines on proliferation of rat T-leukaemic lymphoblasts in vitro. Journal of Reproductive Immunology. 28(3). 263–273. 4 indexed citations

12.

Pöllänen, Pasi, Mikael von Euler, & Olof Söder. (1990). Testicular immunoregulatory factors. Journal of Reproductive Immunology. 18(1). 51–76. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact